Authors:
Glosemeyer, R
Deppe, H
Dormann, AJ
Wigginghaus, B
Stolte, M
Stadler, R
Huchzermeyer, H
Citation: R. Glosemeyer et al., Ulcerative esophagitis and colitis as a rare manifestation in Adamantiades-Behcet syndrome, Z GASTROENT, 39(2), 2001, pp. 167-171
Citation: Aj. Dormann et al., The relevance of systemic complications and the different outcomes of subgroups after percutaneous endoscopic gastrostomy (PEG), AM J GASTRO, 96(6), 2001, pp. 1951-1952
Authors:
Dormann, AJ
Wigginghaus, B
Deppe, H
Huchzermeyer, H
Citation: Aj. Dormann et al., Successful treatment of esophageal perforation with a removable self-expanding plastic stent, AM J GASTRO, 96(3), 2001, pp. 923-924
Authors:
Dormann, AJ
Wigginghaus, B
Risius, H
Kleimann, F
Kloppenborg, A
Rosemann, J
Padel, Y
Pohl, R
Baum, HH
Lubbesmeier, A
Schwab, J
Kuhlkamp, V
Gutjahr, W
Lindenburger, W
Schutz, H
Huchzermeyer, H
Citation: Aj. Dormann et al., Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG) - results from a prospective randomized multicenter trial, Z GASTROENT, 38(3), 2000, pp. 229-234
Authors:
Dormann, AJ
Glosemeyer, R
Leistner, U
Deppe, H
Roggel, R
Wigginghaus, B
Huchzermeyer, H
Citation: Aj. Dormann et al., Modified percutaneous endoscopic gastrostomy (PEG) with gastropexy - earlyexperience with a new introducer technique, Z GASTROENT, 38(12), 2000, pp. 933-938
Authors:
Wigginghaus, B
Dormann, AJ
Grunewald, T
Huchzermeyer, H
Citation: B. Wigginghaus et al., Primary palliative treatment of malignant gastric outlet obstruction with a selfexpanding metal stent, DEUT MED WO, 124(5), 1999, pp. 109-113
Authors:
Dormann, AJ
Wigginghaus, B
Risius, H
Kleimann, F
Kloppenborg, A
Grunewald, T
Huchzermeyer, H
Citation: Aj. Dormann et al., A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications, AM J GASTRO, 94(11), 1999, pp. 3220-3224
Authors:
Musch, E
Hogemann, B
Gerritzen, A
Fischer, HP
Wiese, M
Kruis, W
Malek, M
Gugler, R
Schmidt, G
Huchzermeyer, H
Gerlach, U
Dengler, HJ
Sauerbach, T
Citation: E. Musch et al., Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B, HEP-GASTRO, 45(24), 1998, pp. 2282-2294